celecoxib has been researched along with Cytomegalic Inclusion Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pantalone, MR | 1 |
| Martin Almazan, N | 1 |
| Lattanzio, R | 1 |
| Taher, C | 1 |
| De Fabritiis, S | 1 |
| Valentinuzzi, S | 1 |
| Bishehsari, F | 1 |
| Mahdavinia, M | 1 |
| Verginelli, F | 1 |
| Rahbar, A | 1 |
| Mariani-Costantini, R | 1 |
| Söderberg-Naucler, C | 1 |
1 other study available for celecoxib and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer.
Topics: Arachidonate 5-Lipoxygenase; Caco-2 Cells; Celecoxib; Colorectal Neoplasms; Cyclooxygenase 2; Cytome | 2023 |